Stay updated on Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:37:08.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A sitewide announcement says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T13:54:23.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T13:54:07.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T14:10:10.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added, and several legacy documents and metadata entries were removed, indicating a cleanup of historical content rather than new study details.
    Difference
    18%
    Check dated 2026-09-21T21:00:15.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a new version of the page template or content.
    Difference
    0.0%
    Check dated 2026-08-31T16:14:39.000Z thumbnail image

Stay in the know with updates to Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.